Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy EVP, Chief Medical Officer bought 23,250 shares at $8.60 ($199,992)
  5. 4 Open-market buy Director bought 4,000 shares at $7.82 ($31,280)
  6. 4 Grant or award President and CEO acquired 373,200 shares (grant or award)
  7. 4 Open-market sale President & CSO sold 4,000 shares at $12.39 ($49,553)
  8. 4 Open-market sale Chief Executive Officer sold 4,000 shares at $12.39 ($49,553)
  9. 4 Grant or award EVP, Chief Medical Officer acquired 22,013 shares (grant or award)
  10. 4 Grant or award SVP, CFO & Treasurer acquired 22,013 shares (grant or award)
  11. 4 Grant or award EVP, Chief Reg. Affairs acquired 22,013 shares (grant or award)
  12. 4 Grant or award EVP, Chief Dev. Officer acquired 22,013 shares (grant or award)
  13. 4 Grant or award Chief Commercial Officer acquired 15,849 shares (grant or award)
  14. 4 Grant or award President & CSO acquired 114,400 shares (grant or award)
  15. 4 Grant or award Chief Executive Officer acquired 114,400 shares (grant or award)
  16. 4 Open-market sale EVP, Chief Medical Officer sold 1,186 shares at $14.83 ($17,590)
  17. 4 Open-market sale EVP, Chief Dev. Officer sold 2,887 shares at $14.83 ($42,818)
  18. 4 Open-market sale President & CSO sold 18,990 shares at $14.83 ($281,644)
  19. 4 Open-market sale Chief Executive Officer sold 18,990 shares at $14.83 ($281,644)
  20. 4 Open-market sale EVP, Chief Reg. Affairs sold 2,046 shares at $15.52 ($31,752)

Page 12 of 31 · 601 filings